Professor Serge Jurasunas' upcoming presentation: "A New Way to Approach Cancer". This presentation is for the Medicine Week Congress in Baden Baden Germany, October 30 thru November 3rd, 2019.
Can Food Diet Prevent and Be Efficient In Cancer Treatment?Sheldon Stein
In this paper Professor Jurasunas writes about food diet and nutrition in cancer prevention and treatment. He shares his knowledge about what he has learned about the role of food diet from his 50 years of clinical experience in cancer treatment, emphasizing the role of diet, nutrition, and antioxidants in naturopathic oncology. He also gives recipes for a juice cocktail, special soup and an energy drink. Good nutrition and a healthy food diet a useful adjunct and foundation for cancer prevention and treatment.
How to Understand and Treat Cancer with Modern Methods. Public Presentation B...Sheldon Stein
Professor Serge Jurasunas' Public Presentation on the New Modern Way to Treat Cancer - Strategic Immunotherapy, Apoptosis, Angiogenesis at the Biobran Workshop in Zagreb, Croatia, 2-27-2018.
Professor Serge Jurasunas - New Modern Way to Approach Cancer - Biobran Works...Sheldon Stein
How to Treat Cancer with Immunotherapy Utilizing Biobran through the Microbiome. Professional Presentation for Medical Practitioners with Clinical Cases By Professor Serge Jurasunas.
New Modern Way to Approach Cancer - 5th International Biobran WorkshopSheldon Stein
New Modern Way to Approach Cancer - 5th International Biobran Workshop Krakow , Poland June 9-11, 2017. Professor Jurasunas discusses the problems of conventional oncology and offers insight into less toxic and more efficient methods of cancer treatment. He offers case histories and reviews protocols
using Biobran and other modern methods against cancer, focusing on Strategic Immunotherapy, Apoptosis and Angiogenesis. He shows how Biobran improves cancer survival rates and metastases prevention and disease recurrence.
How to Understand and Treat Cancer with Molecular MarkersSheldon Stein
How to Understand and Treat Cancer with Molecular Markers by Professor Serge Jurasunas, N.D., M.D. (Hom)
This is the first in a series of presentations on Naturopathic Oncology.
For More Information Visit: www.sergejurasunas.com
Naturopathic Oncology - Anti-Oxidants - Second in a SeriesSheldon Stein
Professor Serge Jurasunas N.D., M.D. (Hon.) addresses the use of antioxidants in the treatment of cancer, given in Paris, France 2008, at the Anti-Aging Medicine World Congress. This was a workshop for the participants. For further information: www.sergejurasusas .com
Can Food Diet Prevent and Be Efficient In Cancer Treatment?Sheldon Stein
In this paper Professor Jurasunas writes about food diet and nutrition in cancer prevention and treatment. He shares his knowledge about what he has learned about the role of food diet from his 50 years of clinical experience in cancer treatment, emphasizing the role of diet, nutrition, and antioxidants in naturopathic oncology. He also gives recipes for a juice cocktail, special soup and an energy drink. Good nutrition and a healthy food diet a useful adjunct and foundation for cancer prevention and treatment.
How to Understand and Treat Cancer with Modern Methods. Public Presentation B...Sheldon Stein
Professor Serge Jurasunas' Public Presentation on the New Modern Way to Treat Cancer - Strategic Immunotherapy, Apoptosis, Angiogenesis at the Biobran Workshop in Zagreb, Croatia, 2-27-2018.
Professor Serge Jurasunas - New Modern Way to Approach Cancer - Biobran Works...Sheldon Stein
How to Treat Cancer with Immunotherapy Utilizing Biobran through the Microbiome. Professional Presentation for Medical Practitioners with Clinical Cases By Professor Serge Jurasunas.
New Modern Way to Approach Cancer - 5th International Biobran WorkshopSheldon Stein
New Modern Way to Approach Cancer - 5th International Biobran Workshop Krakow , Poland June 9-11, 2017. Professor Jurasunas discusses the problems of conventional oncology and offers insight into less toxic and more efficient methods of cancer treatment. He offers case histories and reviews protocols
using Biobran and other modern methods against cancer, focusing on Strategic Immunotherapy, Apoptosis and Angiogenesis. He shows how Biobran improves cancer survival rates and metastases prevention and disease recurrence.
How to Understand and Treat Cancer with Molecular MarkersSheldon Stein
How to Understand and Treat Cancer with Molecular Markers by Professor Serge Jurasunas, N.D., M.D. (Hom)
This is the first in a series of presentations on Naturopathic Oncology.
For More Information Visit: www.sergejurasunas.com
Naturopathic Oncology - Anti-Oxidants - Second in a SeriesSheldon Stein
Professor Serge Jurasunas N.D., M.D. (Hon.) addresses the use of antioxidants in the treatment of cancer, given in Paris, France 2008, at the Anti-Aging Medicine World Congress. This was a workshop for the participants. For further information: www.sergejurasusas .com
Immuno-Oncology: An Evolving Approach to Cancer Care
Review a downloadable slide deck by Thomas F. Gajewski, MD, PhD, covering the most clinically relevant new data reported from Immuno-Oncology: An Evolving Approach to Cancer Care.
Target Audience
This activity is designed to meet the educational needs of oncologists and other healthcare professionals involved in cancer care.
Format: Microsoft PowerPoint (.ppt) | File size: 26.2 MB | Date posted: 6/20/2012
Slide Deck Disclaimer
This slide deck in its original and unaltered format is for educational purposes and is current as of June 2012. All materials contained herein reflect the views of the faculty, and not those of IMER, the CE provider, or the commercial supporter. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should not rely on this information as a substitute for professional medical advice, diagnosis, or treatment. The use of any information provided is solely at your own risk, and readers should verify the prescribing information and all data before treating patients or employing any therapeutic products described in this educational activity.
Usage Rights
This slide deck is provided for educational purposes and individual slides may be used for personal, non-commercial presentations only if the content and references remain unchanged. No part of this slide deck may be published in print or electronically as a promotional or certified educational activity without prior written permission from IMER. Additional terms may apply. See Terms of Service on IMERonline.com for details.
Immunotherapy in India is most promising treatment for almost all types of cancers with No side effects. Hospitals like Cancer Healer Center provides such type of treatment in very affordable cost.
In this presentation, I discuss a new standard of treatment in cancers which is immunotherapy. I also discuss the few cancers for which it has been approved.
This presentation is part of MIU CE Pharmacy Program and is designed primarily for pharmacists with the following learning objectives:
1- Explain the mechanisms of action behind immune response to cancer and the application of immunotherapy in cancer treatment
2- Distinguish new and emerging immunotherapy classes and individual agents efficacy, safety to therapy in cancer treatment
3-Strategies to counsel and assist patients to overcome barriers to therapy, including Treatment side effects to improve adherence to therapy
Cancer Immunotherapies (Focus on Melanoma & Lung Cancers)Zeena Nackerdien
Effective immunotherapy i.e. enlisting the patient’s own immune system to fight disease may mark a milestone in the fight against certain cancers. Three lymphocytes – T cells, B cells and NK-cells – involved in specific immune responses against cancers and other diseases. T cells recognize specific antigens via a T-cell antigen-receptor. The two main types of T cells, CD4- and CD8 T-cells, are categorized according to their respective CD4 and CD8 surface markers. The latter group includes cytotoxic T cells, also known as killer T lymphocytes. These cells kill invading pathogens or other disease-causing agents. Scientists discovered that a type of protein receptor, cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), prevented T cells from launching immune attacks [1]. In the early 1990s, another “brake” was discovered in dying T cells namely programmed death 1 or PD-1. The rationale underlying cancer immunotherapy is that exposing CTLA-4, PD-1 or using other appropriate immune-system-based therapies may enable the activation of the immune system to destroy cancer.
Genetically engineering a patient’s T cells to target tumor cells marked one of the promising turning points in cancer immunotherapy, particularly for certain blood cancers and solid tumors. Melanoma and lung cancer, two often-fatal diseases, are treatable in the early stages with surgery or other standards of care. However, some patients are diagnosed during the later stages of the disease or relapse with refractory/unresectable tumors. For these subgroups, the latest National Comprehensive Cancer Network (NCCN) tailored algorithms coupled with systemic treatment options, including immunotherapies, could potentially improve outcomes. Here, I summarize the latest approved immunotherapies mentioned in the NCCN guidelines, along with other examples of investigational agents such as monoclonal antibodies, cancer vaccines, and natural killer cells. Additional examples of targeted therapies, novel “druggable” and other immunotargets are presented in the section, ”Future Directions.”
Reference
1. Couzin-Frankel, J., Breakthrough of the year 2013. Cancer immunotherapy. Science, 2013. 342(6165): p. 1432-3.
Sasha Stanton, MD, PhD of the Tumor Vaccine Group at the University of Washington discusses vaccine research and its role in the treatment of cancer, particularly as it relates to breast cancer, ovarian cancer and DCIS.
This intro is geared towards interested novices who wish to find a resource that can serve as a starting point for further self-study. This is not meant to replace a doctor's advice. Please approach a medical professional for any health condition.
Immuno-Oncology: An Evolving Approach to Cancer Care
Review a downloadable slide deck by Thomas F. Gajewski, MD, PhD, covering the most clinically relevant new data reported from Immuno-Oncology: An Evolving Approach to Cancer Care.
Target Audience
This activity is designed to meet the educational needs of oncologists and other healthcare professionals involved in cancer care.
Format: Microsoft PowerPoint (.ppt) | File size: 26.2 MB | Date posted: 6/20/2012
Slide Deck Disclaimer
This slide deck in its original and unaltered format is for educational purposes and is current as of June 2012. All materials contained herein reflect the views of the faculty, and not those of IMER, the CE provider, or the commercial supporter. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should not rely on this information as a substitute for professional medical advice, diagnosis, or treatment. The use of any information provided is solely at your own risk, and readers should verify the prescribing information and all data before treating patients or employing any therapeutic products described in this educational activity.
Usage Rights
This slide deck is provided for educational purposes and individual slides may be used for personal, non-commercial presentations only if the content and references remain unchanged. No part of this slide deck may be published in print or electronically as a promotional or certified educational activity without prior written permission from IMER. Additional terms may apply. See Terms of Service on IMERonline.com for details.
Immunotherapy in India is most promising treatment for almost all types of cancers with No side effects. Hospitals like Cancer Healer Center provides such type of treatment in very affordable cost.
In this presentation, I discuss a new standard of treatment in cancers which is immunotherapy. I also discuss the few cancers for which it has been approved.
This presentation is part of MIU CE Pharmacy Program and is designed primarily for pharmacists with the following learning objectives:
1- Explain the mechanisms of action behind immune response to cancer and the application of immunotherapy in cancer treatment
2- Distinguish new and emerging immunotherapy classes and individual agents efficacy, safety to therapy in cancer treatment
3-Strategies to counsel and assist patients to overcome barriers to therapy, including Treatment side effects to improve adherence to therapy
Cancer Immunotherapies (Focus on Melanoma & Lung Cancers)Zeena Nackerdien
Effective immunotherapy i.e. enlisting the patient’s own immune system to fight disease may mark a milestone in the fight against certain cancers. Three lymphocytes – T cells, B cells and NK-cells – involved in specific immune responses against cancers and other diseases. T cells recognize specific antigens via a T-cell antigen-receptor. The two main types of T cells, CD4- and CD8 T-cells, are categorized according to their respective CD4 and CD8 surface markers. The latter group includes cytotoxic T cells, also known as killer T lymphocytes. These cells kill invading pathogens or other disease-causing agents. Scientists discovered that a type of protein receptor, cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), prevented T cells from launching immune attacks [1]. In the early 1990s, another “brake” was discovered in dying T cells namely programmed death 1 or PD-1. The rationale underlying cancer immunotherapy is that exposing CTLA-4, PD-1 or using other appropriate immune-system-based therapies may enable the activation of the immune system to destroy cancer.
Genetically engineering a patient’s T cells to target tumor cells marked one of the promising turning points in cancer immunotherapy, particularly for certain blood cancers and solid tumors. Melanoma and lung cancer, two often-fatal diseases, are treatable in the early stages with surgery or other standards of care. However, some patients are diagnosed during the later stages of the disease or relapse with refractory/unresectable tumors. For these subgroups, the latest National Comprehensive Cancer Network (NCCN) tailored algorithms coupled with systemic treatment options, including immunotherapies, could potentially improve outcomes. Here, I summarize the latest approved immunotherapies mentioned in the NCCN guidelines, along with other examples of investigational agents such as monoclonal antibodies, cancer vaccines, and natural killer cells. Additional examples of targeted therapies, novel “druggable” and other immunotargets are presented in the section, ”Future Directions.”
Reference
1. Couzin-Frankel, J., Breakthrough of the year 2013. Cancer immunotherapy. Science, 2013. 342(6165): p. 1432-3.
Sasha Stanton, MD, PhD of the Tumor Vaccine Group at the University of Washington discusses vaccine research and its role in the treatment of cancer, particularly as it relates to breast cancer, ovarian cancer and DCIS.
This intro is geared towards interested novices who wish to find a resource that can serve as a starting point for further self-study. This is not meant to replace a doctor's advice. Please approach a medical professional for any health condition.
Phytochemical and anti proliferative activity of Nigella sativa (Kalonji)Saptarshi Samajdar
Highly potent plant having very useful pharmacological effect especially in anticancer studies and various other diseases. It is even called Panacea because it can cure all diseases except death. Various religious books mention its existence as potent herbal drug.
Prof. Serge Jurasunas Biological Aging vs. Chronological Aging Part 1.pdfSheldon Stein
Biological Aging VS. Chronological Aging - How to Build a Healthy Longevity - An Important Role for the Mitochondria
Part I
Professor Serge Jurasunas, M.D. (hc) N.D. M.D (Hom)
Topics in Part 1:
A Longer Lifespan No Longer Means a Healthier Lifespan
What are the Causes of Normal Aging or Premature Aging?
Mitochondria, Oxidative Stress, and Premature Aging
What are Mitochondria?
Brain Neurons
The Brain and Alzheimer’s
Prof. Serge Jurasunas Biological Aging vs. Chronobiological Aging Part 2.pdfSheldon Stein
Prof. Serge Jurasunas Biological Aging vs. Chronobiological Aging Part 2.pdf
Topics in Part 2:
Food Diet and Healthy Lifespan
The Okinawa Food Model
List of the Best Anti-Aging Foods
Supplements that enhance Anti-Aging and Mitochondria
Protocol for the Treatment Prostate Cancer - Dr Serge JurasunasSheldon Stein
Dr. Serge Jurasunas shares his Prostate Cancer Protocol in this paper, explaining the nature and treatment of Prostate Cancer from a Naturopathic Oncology Perspective. Professor Jurasunas is located in Lisbon Portugal and has lectured worldwide throughout his 50 years as a clinician.
He explains what can be done about the #1 cause of death in males even before lung cancer and what can be done, from the new perspective of Naturopathic Oncology.He offers an example, explains diagnostic procedures with Molecular markers and addresses detox, supplements and treatment.
Further information may be found in his new book, Health and Disease Begin in the Colon" and in his Blog: Naturopathiconcology.blogspot.com .
Professor Jurasunas explains what is cancer and how it develops. He explains the nature of this disease, and why cells mutate, elaborating on P53 and apoptosis. He explains why Cancer is a silent killer, while addressing the cellular cycle.
Health and Disease by Iridology Examination - Professor Serge JurasunasSheldon Stein
Professor Jurasunas offers an introductory overview to the history and practice of Iridology. He draws from his 50 years of clinical practice and offers real life cases, emphasizing the value of Iridology as a diagnostic tool, explaining the relationship between the iris, nervous system, and body's organs, as well as embryological development.
Protocol for the Treatment of Prostate CancerSheldon Stein
Professor of Naturopathic Oncology, Serge Jurasunas explains the nature of prostate cancer and outlines the unique protocols he utilizes at his Lisbon clinic. Additional information is available on his website: www.sergejurasunas.com
Preview - Health and Disease Begin in the ColonSheldon Stein
Health and Disease Begin in the Colon A preview of Professor Serge Jurasunas' new book, now available on Amazon in eBook and paperback formats. www.sergejurasunas.com
Inquiries: sergejurasunas@hotmail.com
IRIDOLOGY RESEARCH BY GAEL RIVERZ N.D., IRIDOLOGISTSheldon Stein
A Presentation of the Work of Professor Serge Jurasunas in the Field of Cancer Detection through Iridology Profiling
(As Described his Last Important Book "Health and Disease Begin in the Colon, Featuring Prof. Serge Jurasunas’ Natural Medicine)
Breast Cancer Theory, Profiling Through Iridology & TherapiesSheldon Stein
Professor Serge Jurasunas offers an in-depth understanding of breast cancer theory, its development, history and treatment. He discusses environmental factors, risk evaluation, genetics and family risk, cellular respiration and treatment innovations back in 2003. You can ask yourself what has happened over the past 13 years since then?
He offers detoxification drinks and formulas, discusses the reversal of mitochondrial damage as well as the need for psychological counseling and support. He then offers several cases.
Please note his new address:
Professor Serge Jurasunas
R.coelho 93 QTA Marinha
2750-008 Cascais
Portugal
Sergejurasunas@hotmail.com
Serge Jurasunas: A Complementary Approach to Breast Cancer - A Case with Mult...Sheldon Stein
A Complementary Approach to Breast Cancer - A Case with Multiple Liver Metastases is Free from Disease . In this paper Professor Jurasunas explains breast cancer, it's development
and treatment. He offers illustrations with Live Blood Microscopy, Oxidative Dried Layer Blood Testing, and his protocol for a successful outcome.
Serge Jurasunas: Oxygen, Mitochondria and CancerSheldon Stein
Oxygen, Mitochondria and Cancer - In this well documented paper Professor Jurasunas explains the role of Mitochondria and Oxygen play in cancer development and treatment, discussing ATP, genetic mutation, treatment protocol and nutrition.
Serge Jurasunas: Clinical Evidence of Cellular Respiration to Target CancerSheldon Stein
In this paper, Professor Jurasunas discusses clinical evidence on cellular respiration and its use in treating cancer. He offers documentation, dietary advice and documentation, along with protocols.
Integrative Cancer - New theories and Advances in Treatment From Hippocrates ...Sheldon Stein
Professor Serge Jurasunsas' recent paper on Integrative Cancer, From Hippocrates to the Human Genome - posted on his behalf. Discusses testing, protocols and case discussion.
Naturopathic Oncology-Health Begins In The Colon As Seen through Iridology-Ho...Sheldon Stein
Naturopathic Oncology-Health Begins In The Colon As Seen through Iridology - How To Detoxify - Professor Serge Jurasunas
Professor Serge Jurasunas' Presentation for the International Physician Round Table in Tampa Fl. , January 2016
www.sergejurasunas.com
P53 Tumor Suppressor Gene: Understanding P53 Based Dietary Anti Cancer Thera...Sheldon Stein
The P53 tumor suppressor gene which has been dubbed both the “Guardian of the Genome” (Lane 1992) and Science “Molecule of the Year”, is directly involved in the initiation of apoptosis and programmed cell death, to prevent an accumulation of abnormal cells. However apoptosis evasion is a characteristic feature of human cancers that promote tumor formation and progression (1). Presently, P53 is known to play a key role in practically all types of human cancers, and the mutation or loss of P53 gene function, can be identified in more than 50% of all human cancer cases worldwide.
This paper was uploaded on behalf of Professor Serge Jurasunas of Lisbon Portugal, www.sergejurasunas.com
The paper goes on to explain the role of the P53 gene and its relationship to Cancer and Apoptosis. It then elaborates on the importance of dietary agents can have a beneficial impact in cancer treatment, and provides a number of case studies. He addresses the importance of the P53 gene and DNA repair, as well as his use of Molecular Markers testing.
Professor Jurasunas believes:
We urgently need to put into clinical practice what we have discovered and learned. Targeting P53 and other genes remain one of the greatest challenges in the treatment of cancer. We have been working now for over 8 years with molecular markers as a diagnostic, prognosis, and follow up to treatment, selected the appropriate bioactive dietary compounds or anticancer agents, exceeding 1000 cases, blood tests, and successes. This may be an incentive for more doctors to venture into this new direction in order to achieve more beneficial results with their patient treatment, especially in cases where we can verify the ones who would be refractory to chemotherapy and have a poor response. It is always best to first check through patient testing, to determine whether or not chemotherapy would be beneficial.
Naturopathic Oncology - Nutritional Treatment - Third in a SeriesSheldon Stein
In this workshop given by Professor Serge Jurasunas, N.D., M.D. (Hom.) on Naturopathic Oncology, covering nutrition, diet and lifestyle, especially after remission or cure, as well as dietary prevention. This workshop was given at the 2008 Anti-Aging World Congress in Paris, France. Even more so these nutritional principles hold true today. Please visit: www.sergejurasunas.com , for more information.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
1. How to Boost NK Cell Activity by using Rice Bran Arabinoxylan/BioBran and
Other Natural Compounds in the Treatment of Cancer
30.10 – 3.11.2019
Medizinische Woche
Krebskongress
Baden – Baden
Germany
NEW MODERN WAY TO APPROACH CANCER
Speaker: Serge Jurasunas N.D. M.D (Hc) M.D. (Hom)
Professor of Naturopathic Oncology
www.sergejurasunas.com
2. Serge Jurasunas, N. D. , M. D. (Hom)
• Over 50 years of practice.
• 35 years using integrative cancer methods.
• Interest in Nutrition, Live Blood Analytics, Oxidative dried blood testing,
Iridology, Detox, Oxidative Stress
• Developed several innovative cancer therapies.
• During the past 12 years involved in the research and practical application of 53
tumor suppressor genes and other apoptotic players.
• Runs a large clinic in Lisbon over 38 years.
• Published over 150 papers, conferences articles.
• Author of 8 books and several booklets
blog: https://naturopathiconcology.blogspot.com
email: sergejurasunas@gmail.com
2
4. Video from a Researcher at the University of Singapore
(From My Science Work)
A number of recent articles published in various countries have shown that
reactivating the immune system to treat cancer is now attracting Oncologists.
4
Reactivating the Immune System Against Cancer: A Role for Natural Compounds
5.
6. NK Cell- Based Immunotherapy in Cancer Metastasis
NK Cells are our First
Line of Defence
Against Cancer
7. • NK cells are component of the innate immune
response against viruses and malignant cells.
• NK cells were first described in early 1970 on a
functional basis according to their ability to kill
tumor cells directly in the absence of stimulation.
• NK cells are bone-marrow derived and they
represent only 5-15% of the total lymphocyte
population.
• NK cells have anti-tumor targeting enabling them
to migrate to sites of metastasis and eliminate
malignant cells but spare normal cells.
9. NATURAL KILLER CELLS = OUR FIRST LINE OF DEFENCENATURAL KILLER CELLS = OUR FIRST LINE OF DEFENCENATURAL KILLER CELLS = OUR FIRST LINE OF DEFENCENATURAL KILLER CELLS = OUR FIRST LINE OF DEFENCE
AGAINST CANCERAGAINST CANCERAGAINST CANCERAGAINST CANCER
• NK cells patrol in the blood and lymphatic system at a resting state.
• NK cells became more active in presence of cancer cells and in response to
cytokines.
• NK cells when activated destroy a cancer cell in 5 minutes and repeat this
process up to 27 times in its lifetime.
10. “Individuals having low NK cell activity
are at risk to develop cancer.”₁
₁ Tmai K., Matsuyama S., Miyake S., Suga K., Nakachi K.
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-
year follow-up study of a general population – Lancet . 2000.356 - 1795-1799
11.
12. - Breakthrough in Immuno-Oncology.
- Boost NK cell activity.
- Using a Arabinoxylan compound/ BioBran derived from
modified rice bran.
- BioBran/MGN-3 = a biological response modifier.
- Developed in 1 990 by Daiwa Japan.
ONE OF THE SAFEST SUPPLEMENTS AVAILABLE TODAY
13. 13
5th International BioBran Workshop, 9-11, June 2017, Krakow, Poland
Oncologist Joseph Brenner M.D., Hegyi Gabriela M.D., Prof.Jurasunas
N.D., Prof. Tibor Hajto, Immuno-Oncologist Prof. Rupert Handgretinger
14. BioBran: A Biological Response ModifierBioBran: A Biological Response ModifierBioBran: A Biological Response ModifierBioBran: A Biological Response Modifier
Rice Bran ArabinoxylanRice Bran ArabinoxylanRice Bran ArabinoxylanRice Bran Arabinoxylan
• BioBran is produced by enzymatic hydrolysis of Hemicellulose
B a dietary fiber found in rice bran containing Arabinoxylan
as its main component.
• It consists of a highly branched and complicated sugar
composition of mainly Arabinose and Xylose obtained from
modified rice bran.
• The long polysaccharide molecules are broken into small
ones after being heated with a Shiitake mycelia mushroom
enzyme.
15. • Before this process the long polysaccharide molecules
cannot be digested and are usually eliminated from the
colon.
The result is an Arabinoxylan derivative with strong
immunomodulatory properties:
STRUCTURE
16. RICE BRAN SHIITAKE MUSHROOM
MYCELIA CULTURE
Extraction with hot water
HEMICELLULOSE B
Shiitake mushroom mycelia removed
CARBOHYDRATE HYDROLYSIS
ENZYME COMPLEX
ACTIVATION
BBioBran
Rice Bran Arabinoxylan
17. DIGESTION, ABSORPTION AND FUNCTION OF BioBran
Dietary fibers are eliminated by the intestine but BioBran is absorbed in the
small intestine practically undigested entering in the blood to become a
nutritional food which activates NK cells optimizing immune function when
taken orally.
18.
19. Cancer patients have the following defects along with
decreasing cytotoxic activity, compared to healthy
individuals.
- Decreased production of perforin and granzymes.
- Decreased binding capacity.
- Defective cytokine production.
- Decreased cytotoxicity.
20. A Strong Link Exists Between Breast Cancer and Natural Killer
(NK) Cells:
Commenting on a 116 patients healed with surgery -
“The more NK cells that are active in the week
following surgery, the better the chances of long
term survival.”
Professor Ronald B. Herberman (Natural Cancer Institute)
Director Institute of Oncology
University of Pittsburg - USA
21. BioBran Increases the Curve of NK cells
If you prescribe 2g of BioBran to
volunteers then you can see a curve of NK
cells increasing about 60% after two
weeks. But if you continue, you can
achieve up to 200 even 300% or more in
NK cell numbers and activity.
Control:
NK cells were here but not activated to
release their toxic enzymes (perforin)
through the membrane of cancer cells.
Ghoneum M. “Enhancement of Human natural killer cells activity by modified
arabinoxylan from rice bran. (MGN-3) Int. Immunotherapy 1998. XIV.89-99
22. Treatment with BioBran causes a remarkable increase in NK cells activity including increase
and release of perforin and granzyme content in cancer patients after 2 weeks.
PERCENTAGE OF REDUCTION
Breast cancer = 154% - 332%
Leukemia = 100% - 240%
Cervical cancer = 100% - 275%
Prostate = 174% - 385%
Multiple Myeloma= 100% - 537%
“ Enhancement of NK cells activity continue to rise at 3-6 months after treatment. “
Ghoneum M. Narmatalla G. N.K Immunomodulatory function in 27 cancer patients by MGN-3, a modified arabinoxylan
from rice bran - The abstract of 87th Annual Meeting of the American Ass. for cancer Research. Wah. D.C April 20-24.1996.
23.
24. BioBran is superior to other immune supplements like mushroom, Arabinoxylan, Maitake
Mushroom – D. Fraction, A H-CC
25. Effect on long-term administration of Immunomodulatory Food (1) on cancer patients
completing conventional therapy- H. Tsunekawa, Tsunekawa Gastrointestinal Clinic.
16 cancer patients mainly in
stage IV, had just undergone
surgery, chemotherapy and
radiotherapy.
Daily diet was based on modern
dietetic food, grains, vegetables,
1-5 kinds of functional food per
day.
BioBran dosage: 3g per day at
each meal.
(1) Maeda H.- The food function of Modified Arabinoxylan from rice bran (MGN-3) Packing of food, 33-
1:2001
26. 26
NK Immunorestoration of Cancer Patients by BioBran/MGN-3
Figure 3: Cytocentrifuge preparation of
two K562 tumor cells undergoing
destruction by one NK cell. NK cells were
activated by MGN-3
a) First step in the process represented by
the binding of an NK cell to tumor cells.
(Giema, X740)
b) Preparation showing one tumor cell is
dead. (Giema, X740)
c) Preparation showing both tumor cells
are dead while an NK cell in between is
still alive. (Giema, X740)
d) Cytocentrifuge preparation showing NK
cell has detached itself from the dead
tumor cells. (Giema, X740)
27.
28. BioBran Enhances the Effect of Chemotherapy Leading to
Effective Treatment at Low Dosage with Less Toxic Effect and More
Results
29.
30. Swiss albino mice were inoculated with Ehrlich Ascites Carcinoma (EAC) cells- the RBAC graph
received 40mg/kg body weight of RBAC intravenously three times a week for a period of 3
weeks, starting after the 8th inoculation of EAC- the control group received phosphate-
buffered saline (PBS)- after the treatment, the result showed a significant reduction in Tumor
size showing tumor regression
31. BioBran MGN-3 reduced side-effects of
chemotherapy for patients with breast cancer,
Nisbitar hospital.
Study: 50 breast cancer patients were investigated
on the effect of BioBran with a daily dose of 3gr:
• Nausea
• Vomiting
• Appetite
• Fatigue
• Weight loss
• Anorexia
80% of women who took BioBran typically benefit
from a significant reduction in side effects.
32.
33.
34.
35. 15g mg/kg/day. Two fold increase in NK cytotoxicity after 1 month of treatment
30g mg/kg/day. Significant enhancement of NK activity. (310% over baseline) after one week and continue to increase. Peak response observed in 2 months of treatment where
NK activity increase fivefold.
Increase to 45 mg/kg/day demonstrate a similar increasing trend in NK activity but the values were higher in magnitude than those of 30 mg/kg/day. Discontinuation of treatment
result in a decline of NK activity.
Treatment of cancer patient: 3gr per day during 2/3 months and reduce to 2 gr per day
36. ADVANTAGEADVANTAGEADVANTAGEADVANTAGESSSS OF TAKING BioBran/ARABINOXYLAN RICE BRANOF TAKING BioBran/ARABINOXYLAN RICE BRANOF TAKING BioBran/ARABINOXYLAN RICE BRANOF TAKING BioBran/ARABINOXYLAN RICE BRAN
•Non-toxic
•Easily absorbed
•Non hyper responsive
•Fast acting
•Natural and GMO free
Supported by intensive scientific and clinical research, chemical trials,
in-vitro and in-vivo in Japan, USA and Europe.
37. Conclusion:
BioBran/MGN-3 Arabinoxylan Rice Bran
Increases NK cell activity and other immune cells.
Increases chemotherapy effectiveness with less side effects.
Reduces tumor size (faster) alone or together.
Prevents metastasis and cancer reoccurrence.
Increased lifespan expectation with better quality of life in
advanced cancers.
Contributes to faster decrease – Antigen Tumor Markers.
Works in synergy with other natural agents such as curcumin.
Can be taken long term without toxicity for up to (7 years).
38.
39. BioBran/Arabinoxylan Rice Bran unlike any other compound
has been the subject of many human trials, tests and
publications in medical journals for over 20 years.
BioBran has been researched in many hospitals and
universities in Japan and the USA. Over 700 hospitals in Japan
use BioBran as a support for chemotherapy.
Studies : Cambridge University, Tokyo Medical and Dental University, Chiba
University, Kobe Women´s College, Kyushu University, Kyoto University, et
al.
40. Why BioBran/Arabinoxylan Rice Bran
When treating a cancer patient the main goal is to first
choose a very efficient, high quality natural compound
with scientific evidence that you can use with safety and
show positive results with your patients.
You may combine two or three components working in
synergy with each other and with chemotherapy to
obtain quicker and better results. - S. Jurasunas
45. Apoptotic effects of MGN-3 (BioBran) and curcumin on U266 cells-
U266 cells were cultured with MGN-3 (50u/m) and curcumin (2.5.5.0. or 10u/m) for 3 days- curcumin
alone increase apoptosis in U266 cells- however when MGN-3 was combined with curcumin the levels
of apoptosis were remarkerly increased by 20.22 and 24% at a curcumin concentration of 2.5.5 and
10u/m representing a 200%-220% and 247% increase in cancer cell apoptosis as compared to the
controlled unhealed cells with either alternative (alone or in combination).
46. Combination TherapiesBoth MGN-3
Arabinoxylan Rice Bran
and curcumin have the
ability to activate
different immune cells
such as NK cells, T-cells,
B-cells, macrophages,
Dendritic cells while
both can restrict Treg
cells recruited by the
tumor to inhibit immune
cells activity (1).
(1) M. Ghoneum, S. Gollapudi- Synergistic apoptotic effect of Arabinoxylan Rice
Bran (MGN-3/BioBran) and curcumin (Tumeric) on human multiple myeloma
cell line U266 in vitro - Neoplasma-58-2.2011
47.
48. Synergistic Effects of BioBran/Arabinoxylan Rice Bran with
Other Natural Components to Target Cancer
CURCUMIN (1)
GENISTEIN (2)
IL-2 (3)
(1) M. Ghoneum, S. Gollapudi- Synergistic apoptotic effect of Arabinoxylan Rice Bran (MGN-3/BioBran) and
curcumin (Tumeric) on human multiple myeloma cell line U266 in vitro - Neoplasma-58-2.2011
(2) Janet M. Pavese, Rebecca L. Farmer- Inhibition of cancer cell invasion and metastasis by genistein- cancer
metastasis- Rev (2 010) 29-465-482
(3) M. Ghoneum and A. Jeweet- Synergistic effect of modified Arabinoxylane (MGN-3) and Low Dose of
recombinant IL-2 on human NK cell activity and TNF-A production - 1998-East Cast Conference - Board
Certification – Exam.15.16.August 1998
49.
50. Genistein Curcumin
• Proapoptotic
• Antiangiogenic potential
• Immunomodulatory
• Inhibit Glycolysis
• Improve Microbiota
• Decrease Telomerase Activity
• Downregulation of TGFB
• Proapoptotic (P53, BAX)
• Antiangiogenic Potential
• Immune Stimulation
• Inhibit NF.K.B. Activity
• Inhibit COX-2 Expression
• Inhibit HER 2/Neu
• Decrease Telomerase Activity
APOPTOSIS
• Antiestrogen Effect – Inhibits EGF and EGFR mediated signaling pathway overexpressed in
breast cancer; involved in cancer progression.
• Aromatase Modulation.
• Interfere with HR2 Signaling Pathway.
Active Dietary Compounds in Breast Cancer
51. Breast cancer stage IV with multiple metastasis to liver, pleura,
bone and right lung:
Recurrence -
After 4 months of chemotherapy scan shows more
dissemination of metastasis.
Treatment: BioBran, Curcumin, Coenzyme-Q10
After 3 months: 60 % improvement
Extract from my book: ‘Cancer Treatment Breakthrough-Immuno-Oncology U sing Rice Bran Arabinoxylan Compound ’
52. F.41 Years – Asympthomatic Prime Lesions 18 cm –
Secondary Lesions 8 cm
Combination of chemotherapy with our complementary treatment
that targets apoptosis, angiogenesis, immune activity – Anticancer
Diet
52
Advanced Gastric Cancer - Results of Blood Analysis
July 2015 April 2015 July 2015 April 2015
Lesion of
30,1 mm
Lesion of
48,7 mm
Lesion of
18 cm
53.
54. X Ray of the Spine
After 3 months of combined
therapy + chemotherapy.
Total elimination of very large
lesions in the illium and spine.
Jurasunas Serge, ND